Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Harumasa, Yoshihara"'
Autor:
Teppei Yoshioka, Tsutomu Nishida, Masahiko Tsujii, Motohiko Kato, Yoshito Hayashi, Masato Komori, Harumasa Yoshihara, Takeshi Nakamura, Satoshi Egawa, Toshiyuki Yoshio, Takuya Yamada, Takamasa Yabuta, Katsumi Yamamoto, Kazuo Kinoshita, Naoki Kawai, Hideharu Ogiyama, Akihiro Nishihara, Tomoki Michida, Hideki Iijima, Ayumi Shintani, Tetsuo Takehara
Publikováno v:
Endoscopy International Open, Vol 03, Iss 01, Pp E39-E45 (2015)
Background and study aims: The number of patients with chronic kidney disease (CKD) is increasing worldwide and gastric cancer sometimes occurs with CKD. However, the safety and feasibility of endoscopic submucosal dissection (ESD) for patients with
Externí odkaz:
https://doaj.org/article/be1607cae174483cbad368f2925d3de0
Autor:
Yoshiiku Kawakami, Eiji Mita, Shuhei Nishiguchi, Hiroshi Kohno, Chitomi Hasebe, Shotaro Sakisaka, Toshihide Shima, Hideyuki Nomura, Yoshiyasu Karino, Teruhisa Morikawa, Hiroshi Yatsuhashi, Akihide Masumoto, Takeshi Okanoue, Masahito Minami, Fumio Imazeki, Masayuki Kurosaki, Harumasa Yoshihara, Kenji Ikeda, Hiromitsu Kumada, Yasuharu Imai, Makoto Oketani, Takashi Kumada
Publikováno v:
Hepatology Research. 46:992-1001
Aim We analyzed the 5-year post-treatment response to peginterferon α-2a (PEG IFN-α-2a) in hepatitis B e-antigen (HBeAg) positive and negative chronic hepatitis B patients. Methods One hundred and thirty-seven chronic hepatitis B (CHB) patients rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571faf5c6eb3bdb3ba49093ec8af1d7d
https://doi.org/10.1111/hepr.12638
https://doi.org/10.1111/hepr.12638
Autor:
Yoshinori Doi, Takayuki Yakushijin, Hiroyuki Fukui, Naoki Hiramatsu, Tomohide Tatsumi, Eijiro Hayashi, Eiji Mita, Fumihiko Nakanishi, Narihiro Shibukawa, Shusaku Tsutsui, Yasuharu Imai, Masahide Oshita, Nobuyuki Tatsumi, Harumasa Yoshihara, Eiichi Morii, Tetsuo Takehara, Ichizo Kobayashi, Akira Kaneko, Yumiko Hori
Publikováno v:
Kanzo. 56:507-517
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f346b64dbd41b5e3f5440a76897ce71
https://doi.org/10.2957/kanzo.56.507
https://doi.org/10.2957/kanzo.56.507
Autor:
Naoki Harada, Toshifumi Itoh, Eiji Mita, Takayuki Yakushijin, Sadaharu Iio, Toshimitsu Hamasaki, Ryoko Yamada, Harumasa Yoshihara, Masahide Oshita, Takuya Miyagi, Naoki Hiramatsu, Norio Hayashi, Shinji Tamura, Yoshinori Doi, Naoki Morishita, Taizo Hijioka, Yuichi Yoshida, Tetsuo Takehara, Kazuhiro Katayama, Tsugiko Oze, Hiroyuki Fukui, Akinori Kasahara, Michio Kato, Tomohide Tatsumi, Yasuharu Imai, Akira Yamada, Hideki Hagiwara, Akira Kaneko
Publikováno v:
Journal of Gastroenterology. 50:785-794
Entecavir (ETV) is one of the first-line nucleoside analogs for treating patients with chronic hepatitis B virus (HBV) infection. However, the hepatocellular carcinoma (HCC) risk for ETV-treated patients remains unclear. A total of 496 Japanese patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c0f8fc5d4fd679612f495f59477cfeb
https://doi.org/10.1007/s00535-014-1010-7
https://doi.org/10.1007/s00535-014-1010-7
Autor:
Yuichi Yoshida, Harumasa Yoshihara, Eiji Mita, Takuya Miyagi, Naoki Hiramatsu, Yoshiaki Inui, Takanori Ito, Yasuharu Imai, Naoki Morishita, Tsugiko Oze, Tetsuo Takehara, Akinori Kasahara, Masami Inada, M. Kato, Norihiro Hayashi, Tomohide Tatsumi, Masahide Oshita, Shinji Tamura, Takayuki Yakushijin, Ryoko Yamada, Naoki Harada
Publikováno v:
Journal of Viral Hepatitis. 22:254-262
Triple therapy with telaprevir, pegylated interferon and ribavirin has been reported to improve antiviral efficacy but have potentially severe adverse effects in patients with chronic hepatitis C. To avoid the severe effects of telaprevir, lowering t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4eabbbc365891bf4d8b6bf6c439828c
https://doi.org/10.1111/jvh.12289
https://doi.org/10.1111/jvh.12289
Autor:
Yuichi Yoshida, Eiji Mita, Norio Hayashi, Harumasa Yoshihara, Toshimitsu Hamasaki, Hiroyuki Fukui, Masanori Miyazaki, Yoshiaki Inui, Masami Inada, Toshifumi Ito, Takuya Miyagi, Eijiro Hayashi, Taizo Hijioka, Yasuharu Imai, Michio Kato, Tomohide Tatsumi, Naoki Hiramatsu, Tsugiko Oze, Akinori Kasahara, Atsuo Inoue, Hideki Hagiwara, Tetsuo Takehara, Masahide Oshita, Kazuhiro Katayama, Shinji Tamura, Takayuki Yakushijin, Akira Yamada
Publikováno v:
Clinical Gastroenterology and Hepatology. 12:1186-1195
In patients with chronic hepatitis C virus (HCV) infection, lack of sustained virologic response (SVR) 24 weeks after the end of interferon therapy is a significant risk factor for hepatocellular carcinoma (HCC). Although many pretreatment factors ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1892c19bee230a50dcf59b0497ed09c8
https://doi.org/10.1016/j.cgh.2013.11.033
https://doi.org/10.1016/j.cgh.2013.11.033
Autor:
Akira Yamada, Takayuki Yakushijin, Yoshiaki Inui, Tsugiko Oze, Akinori Kasahara, Kunio Suzuki, Yuichi Yoshida, Ryoko Yamada, Yasuharu Imai, Naoki Harada, Masahide Oshita, Shinji Tamura, Norio Hayashi, Takuya Miyagi, Harumasa Yoshihara, Akira Kaneko, Tomohide Tatsumi, Naoki Morishita, Tetsuo Takehara, Naoki Hiramatsu
Publikováno v:
Journal of Gastroenterology. 50:313-322
Triple therapy with telaprevir (TVR), pegylated interferon and ribavirin has improved antiviral efficacy in patients with chronic hepatitis C (CH-C). However, the severe adverse effects caused by TVR are important to resolve. In this prospective, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df083d195cd3cecbe827d500ed1a96ac
https://doi.org/10.1007/s00535-014-0965-8
https://doi.org/10.1007/s00535-014-0965-8
Autor:
Yoshinori Doi, Sadaharu Iio, Akira Yamada, Masahide Oshita, Shinichi Kiso, Atsushi Hosui, Mika Kurokawa, Takayuki Yakushijin, Yuichi Yoshida, Tsugiko Oze, Akinori Kasahara, Eiji Mita, Kazuhiro Katayama, Masanori Miyazaki, Eijirou Hayashi, Akira Kaneko, Harumasa Yoshihara, Hideki Hagiwara, Yasuharu Imai, Toshifumi Ito, Takuya Miyagi, Tatsuya Kanto, Yoshiaki Inui, Naoki Hiramatsu, Hisashi Ishida, Norio Hayashi, Kiyoshi Mochizuki, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
Journal of Gastroenterology. 47:577-585
Nucleotide analogues have recently been approved for the treatment of patients with hepatitis B virus (HBV) infection. However, it is still controversial whether the decrease of HBV-DNA amount induced by treatment with nucleotide analogues can reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0da60346f219ed11f059a702a86b978
https://doi.org/10.1007/s00535-011-0522-7
https://doi.org/10.1007/s00535-011-0522-7
Autor:
Yukinori Yamada, Shoichiro Kawai, Hironao Sueyoshi, Harumasa Yoshihara, Masako Sato, Shunsuke Yoshii, Motohiro Hirao, Toshiaki Doi, Masato Komori, Teppei Yoshioka, Masateru Okawa
Publikováno v:
Kanzo. 53:741-747
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed9614a61e9e9f4fa269f2b7a7df430
https://doi.org/10.2957/kanzo.53.741
https://doi.org/10.2957/kanzo.53.741
Autor:
Harumasa Yoshihara, Tomohide Tatsumi, Eiji Mita, Hideki Hagiwara, Nao Kurashige, Tsugiko Oze, Yoshiaki Inui, Akinori Kasahara, Takayuki Yakushijin, Takuya Miyagi, Kazuhiro Katayama, Naoki Hiramatsu, Tatsuya Kanto, Masahide Oshita, Norio Hayashi, Shinji Tamura, Yuko Inoue, Kiyoshi Mochizuki, Yasuharu Imai, Tetsuo Takehara, Shinichi Kiso
Publikováno v:
Journal of Gastroenterology. 46:1335-1343
The antiviral effect of pegylated interferon (Peg-IFN) plus ribavirin combination therapy in chronic hepatitis C (CHC) patients with normal alanine aminotransferase (ALT) levels (N-ALT) has been reported to be equivalent to that for patients with ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e94d97ae19119eefb7f841ab5cbbd9c
https://doi.org/10.1007/s00535-011-0455-1
https://doi.org/10.1007/s00535-011-0455-1